Editas Medicine, Inc. SEC filings EDIT
Editas Medicine, Inc. has 727 filings in SEC EDGAR's recent list, going back to Aug 18, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Apr 28, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 8, 2026 | — |
| EFFECT | Filing | Mar 21, 2025 | — |
| POSASR | Filing | Mar 5, 2025 | — |
| CT ORDER | Filing | Oct 15, 2021 | — |
| CT ORDER | Filing | Jul 13, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 23, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 23, 2021 | — |
| CT ORDER | Filing | Apr 27, 2020 | — |
| CT ORDER | Filing | Dec 26, 2019 | — |
| CT ORDER | Filing | Oct 24, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 26, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 23, 2019 | — |
| CT ORDER | Filing | Oct 25, 2018 | — |
| CT ORDER | Filing | Oct 18, 2018 | — |
| CT ORDER | Filing | Oct 18, 2018 | — |
| CT ORDER | Filing | Oct 18, 2018 | — |
| CT ORDER | Filing | Nov 14, 2017 | — |
| CT ORDER | Filing | Jun 21, 2017 | — |
| EFFECT | Filing | Apr 3, 2017 | — |
| CORRESP | Letter to the SEC | Mar 30, 2017 | — |
| EFFECT | Filing | Mar 15, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2017 | — |
| CORRESP | Letter to the SEC | Mar 13, 2017 | — |
| CT ORDER | Filing | Mar 1, 2017 | — |
| CT ORDER | Filing | Nov 28, 2016 | — |
| CT ORDER | Filing | Feb 4, 2016 | — |
| CERTNAS | Auto-generated paper document | Feb 2, 2016 | — |
| EFFECT | Filing | Feb 2, 2016 | — |
| 8-A12B | Filing | Jan 29, 2016 | — |
| CORRESP | Letter to the SEC | Jan 29, 2016 | — |
| CORRESP | Letter to the SEC | Jan 29, 2016 | — |
| CORRESP | Letter to the SEC | Jan 5, 2016 | — |
| DRS/A | Filing | Dec 15, 2015 | — |
| DRSLTR | Filing | Dec 14, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2015 | — |
| DRSLTR | Filing | Nov 20, 2015 | — |
| DRS/A | Filing | Nov 20, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2015 | — |
| DRS | Filing | Oct 16, 2015 | — |
| D | Filing | Aug 18, 2015 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- EDIT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1650664
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.